ARA-290 (Injectable) in New Mexico

Pepti serves all of New Mexico. A physician licensed in New Mexico reviews every order within 4 hours, the prescription is compounded by a state-licensed, FDA-registered pharmacy, and it ships free and tracked to any New Mexico street address. The price is the same as every other state.

Yes. The whole process is online in New Mexico: a free assessment, physician review, messaging, dose changes, and refills through your Pepti account or the Hello Pepti app. No clinic visit is required.

Pepti ships ARA-290 to New Mexico directly from the pharmacy: free, tracked, unbranded, in insulated packaging with ice packs for refrigerated medication. The pharmacy ships the next business day and it arrives overnight. PO Boxes are not accepted.

Every treatment on Pepti's catalog ships to New Mexico. Eligibility is confirmed during the assessment from your New Mexico shipping address, and if anything ever cannot ship to your address it is refunded.

The same as everywhere Pepti serves: one all-in monthly price per treatment that includes the medication, the physician, and shipping, with no New Mexico-specific markup and no membership or consult fee. Every price is on the product page.

Yes. Pepti's physicians hold licenses in New Mexico, and only a physician licensed where you live reviews and prescribes your order. Their names and credentials are on the providers page.

Yes. Pepti's partner pharmacies are state-licensed, FDA-registered 503A compounding pharmacies licensed to dispense into New Mexico, and every batch is independently tested before it ships.

ARA-290 is a peptide made from a fragment of erythropoietin, the hormone that protects tissue, and is studied for burning, tingling and numbness from damaged small nerve fibers. It works on the body's repair pathway rather than dulling pain. Compounded; not FDA-approved. ARA-290 is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.

ARA-290 is commonly prescribed for: Adults with burning, tingling or numb feet and hands their physician has evaluated; People with nerve symptoms tied to diabetes, prediabetes or an autoimmune condition; Patients who want a repair-focused option instead of, or alongside, pain medication; Someone who tried standard nerve medications and did not tolerate the side effects. Whether it is appropriate for you is decided by the reviewing physician from your history, medications, and labs where required.

Yes. ARA-290 is prescription-only. The free online assessment takes about five minutes, a physician licensed in New Mexico reviews it within 4 hours, and if approved the prescription goes to the pharmacy. If not approved, the medication charge is refunded.

No. ARA-290 can be prescribed from the assessment alone. If your physician wants labs for your care, they'll ask through your account; upload a recent lab report from any lab at no charge, or order Pepti's at-home panel.

ARA-290 is a subcutaneous injection into the abdomen or thigh with a small insulin syringe. Your kit ships with sterile syringes and alcohol prep pads, and the exact dose and schedule are printed on the pharmacy label. Dosing videos are in your account.

One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.

Once per fill, $219 each time, when the next vial ships. It renews until you cancel, which you can do anytime from your account with no cancellation fee.

The compounded ARA-290 with sterile syringes and alcohol prep pads, free tracked shipping in an unbranded box with insulated packaging, the physician review, ongoing physician care and dose adjustments, and unlimited messaging.

Reported side effects of ARA-290 are usually mild: mild redness or swelling at injection site; temporary fatigue or headache; mild nausea (uncommon). The physician screens your history, medications, and allergies before prescribing, the medication-specific consent lists the known risks, and you can message your physician about anything you notice. Seek emergency care for severe symptoms.

Response varies by person, goal, and dose, and ARA-290 is prescribed for ongoing use rather than a short trial. Your physician sets expectations at approval, tracks how you respond through your account, and adjusts the dose without an appointment.

Yes. Request it from your account or the app; your physician approves or declines. If approved you pay for the additional medication at the pharmacy's cost and the new dose applies to your next shipment.

Yes. Add ARA-290 to a plan with another treatment and both go through one assessment and one physician review, shipping together on one schedule. Each keeps its own catalog price. The physician reviews the combination and can adjust it.

No. Compounded ARA-290 is not FDA-approved. It is prepared to your physician's prescription by a state-licensed, FDA-registered 503A pharmacy and every batch is independently tested before release.

Yes, when prescribed by a licensed physician and dispensed by a licensed pharmacy, which is how Pepti provides it in New Mexico. Research-use-only ARA-290 sold without a prescription is labeled not for human use and is a different product.

ARA-290 switches on the body's tissue-repair receptor, the same one erythropoietin uses to protect cells after injury. At Pepti it is prescribed to support studied for nerve pain and tingling, supports the body's own repair signal, not an opioid, not a sedative, daily injection, monday to friday. Individual response varies, and your physician sets expectations at approval.

ARA-290 switches on the body's tissue-repair receptor, the same one erythropoietin uses to protect cells after injury. Unlike erythropoietin it does not raise red blood cell counts, so it is studied purely for repair, especially of the small nerve fibers behind burning and tingling pain. Compounded ARA-290 is not FDA-approved; it is prescribed off-label by a licensed physician after reviewing your assessment.

ARA-290 is prescribed for studied for nerve pain and tingling, supports the body's own repair signal, not an opioid, not a sedative, daily injection, monday to friday. It is commonly requested by adults with burning, tingling or numb feet and hands their physician has evaluated; people with nerve symptoms tied to diabetes, prediabetes or an autoimmune condition; patients who want a repair-focused option instead of, or alongside, pain medication; Someone who tried standard nerve medications and did not tolerate the side effects. Whether it is appropriate for you is the reviewing physician's decision.

ARA-290 is studied for studied for nerve pain and tingling, supports the body's own repair signal, not an opioid, not a sedative, daily injection, monday to friday. Those are the goals it is prescribed to support at Pepti; results vary by person, dose, and consistency, and no outcome is guaranteed. Your physician tracks how you respond through your account.

Two mid-stage trials in people with small-fiber nerve damage from sarcoidosis (Heij and colleagues 2012, Dahan and colleagues 2013) reported less neuropathic pain and regrowth of nerve fibers measured in the eye. Larger late-stage trials have not been completed. References are listed on this page.

ARA-290 is generally not prescribed with: active cancer or history of cancer (unless approved by oncologist); pregnancy or breastfeeding; severe kidney or liver disease; known allergy to the peptide or excipients. The physician screens for these in your intake, and anything that rules ARA-290 out means it is not prescribed and is refunded.

At Pepti. Complete the free assessment, a physician licensed in New Mexico reviews it within 4 hours, and if appropriate ARA-290 is compounded by a state-licensed, FDA-registered pharmacy and shipped free to your door for $219 per month, all-in. Not prescribed means refunded.

Injectable vial: 5 mL at 2 mg/mL, containing 10 mg ARA-290. One vial is your monthly supply at the prescribed dose, and a fresh one ships about every 28 days.

Not currently. ARA-290 ships as a multi-dose vial with sterile syringes and prep pads. The pepti Pen is available for 24 other treatments.

$219 per month covers the compounded ARA-290, the physician review, ongoing physician care including dose adjustments and refill review, unlimited messaging, and free tracked shipping. There is no membership, consult, visit, or refill fee; the only separate charges are optional at-home lab panels and a physician-approved dose increase billed at pharmacy cost.

Yes. ARA-290 is on Pepti's live catalog, which lists only treatments a partner pharmacy can compound and ship today. If a physician prescribes it, it ships; if it ever cannot be dispensed, the charge is refunded.

ARA-290 ships to 49 states and Washington, D.C, free and tracked, in insulated unbranded packaging. Eligibility is confirmed during the assessment from your shipping address.